ECM
MDRX

Everence Capital Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

Everence Capital Management’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,450
Closed -$141K – 780
2023
Q4 		$141K Hold
13,450
– – 0.01% 734
2023
Q3 		$177 Sell
13,450
-9,870
-42% -$129K 0.01% 696
2023
Q2 		$275K Hold
23,320
– – 0.02% 553
2023
Q1 		$304 Hold
23,320
– – 0.02% 535
2022
Q4 		$411 Hold
23,320
– – 0.04% 436
2022
Q3 		$355K Hold
23,320
– – 0.03% 460
2022
Q2 		$346K Buy
23,320
+6,890
+42% +$129K 0.03% 463
2022
Q1 		$370K Hold
16,430
– – 0.03% 499
2021
Q4 		$303K Hold
16,430
– – 0.02% 583
2021
Q3 		$220K Hold
16,430
– – 0.02% 666
2021
Q2 		$304K Hold
16,430
– – 0.03% 558
2021
Q1 		$247K Hold
16,430
– – 0.02% 621
2020
Q4 		$237K Hold
16,430
– – 0.02% 598
2020
Q3 		$134K Buy
+16,430
New +$134K 0.01% 642

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Everence Capital Management's MDRX Position: Q1 2024 in Review

Everence Capital Management sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 13,450 shares — an estimated $141K sold.

Everence Capital Management first reported a position in MDRX in Q3 2020 and held it in 14 quarters. The position peaked at $370K in Q1 2022. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Everence Capital Management reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Everence Capital Management sold 13,450 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $141K.
  • Everence Capital Management first reported a position in Veradigm Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Everence Capital Management's Veradigm Inc. Common Stock position peaked at $370K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Everence Capital Management's 13F filing for Q1 2024, filed 8 May 2024.